| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/30/2003 | EP1330242A2 Antiproliferative colchicine compositions and uses thereof |
| 07/30/2003 | EP1252141B1 Tosylproline analogs as thymidylate synthase inhibitors |
| 07/30/2003 | EP1180035A4 NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1$g(a), 25-DIHYDROXY VITAMIN D 3? |
| 07/30/2003 | EP1171100B1 Solubilized pharmaceutical composition for parenteral administration |
| 07/30/2003 | EP1082962B1 Utilization of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factors nf-(k)b |
| 07/30/2003 | EP1000078B1 Hybrid anthracyclines from genetically engineered streptomyces galilaeus strains |
| 07/30/2003 | EP0946541B1 Quinolines and their therapeutic use |
| 07/30/2003 | EP0942780B1 Coated particles, methods of making and using |
| 07/30/2003 | EP0902022B1 Novel benzofuranone derivatives and process for producing the same |
| 07/30/2003 | EP0859628B1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 07/30/2003 | EP0831936B1 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy |
| 07/30/2003 | CN1433469A Therapeutically useful synthetic oligonucleotides |
| 07/30/2003 | CN1433425A Unsaturated 14,15-cyclopropane-cendrostanes, a method for their production and pharmaceutical compositions containing these compounds |
| 07/30/2003 | CN1433424A 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 07/30/2003 | CN1433423A Mono and disaccharide derivatives |
| 07/30/2003 | CN1433416A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamideinhibitors of cyclin dependent kinases |
| 07/30/2003 | CN1433415A N-[5-[[[5-alkyl-2-oxazlyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 07/30/2003 | CN1433414A Benzazole derivatives and their use as JNK modulators |
| 07/30/2003 | CN1433412A Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 07/30/2003 | CN1433410A CDK inhibitors having 3-hydroxychromen-4-one structure |
| 07/30/2003 | CN1433408A Aminothiazole inhibitors of cyslin dependent kinases |
| 07/30/2003 | CN1433406A BenzoÒÇöaÒÇòphenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and Ôàí" |
| 07/30/2003 | CN1433405A Quinazoline compounds |
| 07/30/2003 | CN1433396A Pharmaceutical compounds |
| 07/30/2003 | CN1433316A Biologically active agents and drugs |
| 07/30/2003 | CN1433312A Barbituric acid analogs as therapeutic agents |
| 07/30/2003 | CN1433310A Medicinal compositions containing camptothecin derivative and regulating agent |
| 07/30/2003 | CN1432411A New use of gens mutant of human telomerase inverse transcriptase-like component |
| 07/30/2003 | CN1432407A Method of obtaining body's safe high fever and relevant clinical parameters with malarial parasite |
| 07/30/2003 | CN1432372A Natural medicine for resisting electromagnetic radiation and tumor |
| 07/30/2003 | CN1116411C Process for preparing human Angiostatin transgenic alga |
| 07/30/2003 | CN1116304C Organic compound |
| 07/30/2003 | CN1116288C Urea derivatives as inhibitors of inosine-5'-phospho-dehydrogenase |
| 07/30/2003 | CN1116286C 4-anilinoquinazoline derivatives |
| 07/30/2003 | CN1116285C Bis (acridinecarboxamide) and Bis (phenazinecarboxamide) as antitumour agents |
| 07/30/2003 | CN1116283C Cyanoguanidines as well proliferation inhibitors |
| 07/30/2003 | CN1116281C Acryloyl substituted distamycin derivative, process for preparing them,and use as antitumor and antiviral agents |
| 07/30/2003 | CN1116270C Novel retinoids derivs. |
| 07/30/2003 | CN1116077C Methicine for preventing and curing malignant tumor |
| 07/30/2003 | CN1116050C Medicine pill for dredging thje channel generating and nourishing the blood and removing toxic |
| 07/30/2003 | CN1116039C Molecular dispersion composition with enhanced bioavailability |
| 07/30/2003 | CN1116028C Nano realgar and its preparation |
| 07/29/2003 | US6600058 Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments |
| 07/29/2003 | US6600052 With a ring cyclizing reagent to form the compound of Formula V to yield a compound of Formula V: inhibitors of the cyclooxygenase- II enzyme. and antiinflammatory agents and analgesic pharmaceutical agents. |
| 07/29/2003 | US6600037 4,5-disubstituted-2-aminopyrimidines |
| 07/29/2003 | US6600012 Lipid-modified muc-1 derivatives |
| 07/29/2003 | US6599938 Optionally substituted Schiff base condensation products comprising an amino acid component and a benzaldehyde component, that have MIF (macrophage migration inhibitory factor) antagonist activity |
| 07/29/2003 | US6599932 Highly selective in killing tumor cells but not normal cells |
| 07/29/2003 | US6599925 Cardiovascular disorders; anticancer agents |
| 07/29/2003 | US6599921 Antiproliferative agents against estrogen-dependent cancer cells dibenzothiopyran, dibenzopyran and phenanthrene derivatives |
| 07/29/2003 | US6599918 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans |
| 07/29/2003 | US6599912 Methods and compositions for modulating cell proliferation and cell death |
| 07/29/2003 | US6599908 Fused polycyclic 2-aminopyrimidine derivatives |
| 07/29/2003 | US6599902 For treating or preventing a protein kinase related disorder |
| 07/29/2003 | US6599898 Use of certain substituted caprolactam carbonates and ethers in treating tumors |
| 07/29/2003 | US6599890 Inhibitors of matrix metalloproteinases or the production of tumor necrosis factor |
| 07/29/2003 | US6599879 Therapeutic uses of keratinocyte growth factor-2 |
| 07/29/2003 | US6599875 IL-6 antagonist peptides |
| 07/29/2003 | US6599742 Antisense oligonucleotide inhibition of human serine/threonine protein phosphatase gene expression |
| 07/29/2003 | US6599739 Papillomavirus viral vector for use in the transfer of nucleotide sequences |
| 07/29/2003 | US6599727 Human poly (ADP-ribose) polymerase 2 materials and methods |
| 07/29/2003 | US6599719 For therapy of rheumatoid arthritis, tumors |
| 07/29/2003 | US6599711 Methods and kits for detecting protein kinases |
| 07/29/2003 | US6599709 Method for screening for soluble ligands to a receptor-type tyrosine kinase |
| 07/29/2003 | US6599699 Methods for diagnosing a disorder by assaying for MAGE-3 |
| 07/29/2003 | US6599540 Use of a Serenoa repens extract for the production of a medicament to treat prostate cancer |
| 07/29/2003 | US6599536 Therapy of estrogen-associated disorders |
| 07/29/2003 | US6599528 Mechanically stable pharmaceutical presentations form containing liquid or semisolid surface-active substances |
| 07/29/2003 | US6599502 Intracellular delivery vehicles |
| 07/29/2003 | US6599501 Immunomodulators |
| 07/29/2003 | US6599499 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 07/29/2003 | US6599498 Enhanced magnetic resonance imaging agent and a hematinic agent; carboxyalkylated reduced polysaccharides coated ultrasmall superparamagnetic iron oxides; carboxymethyl reduced dextran as a plasma extender |
| 07/29/2003 | US6599495 Nucleotide and protein sequence of mammastatin and methods of use |
| 07/29/2003 | CA2210444C Keratinocyte growth factor-2 |
| 07/29/2003 | CA2133838C Immunotoxins directed against cd33 related surface antigens |
| 07/29/2003 | CA2123514C Novel benzothiophene derivative |
| 07/29/2003 | CA2114136C Gallium (iii) complexes, process for their obtention and pharmaceutical compositions containing them |
| 07/24/2003 | WO2003060523A1 Imaging agents and methods of imaging naaladase of psma |
| 07/24/2003 | WO2003060149A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/24/2003 | WO2003060148A2 Androgen regulated nucleic acid molecules and encoded proteins |
| 07/24/2003 | WO2003060142A2 Compositions and methods for controlled release |
| 07/24/2003 | WO2003060091A2 Selective melanin-concentrating hormone type -1 receptor agonists |
| 07/24/2003 | WO2003060090A2 Novel cytokine zcytor17 ligand |
| 07/24/2003 | WO2003060085A2 Mammalian neural stem cells, compositions and uses thereof |
| 07/24/2003 | WO2003060082A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 07/24/2003 | WO2003060071A2 Albumin fusion proteins |
| 07/24/2003 | WO2003059987A1 Multidrop tree branching functional polyethylene glycol, the preparation method and the use of it |
| 07/24/2003 | WO2003059973A2 Block copolymers |
| 07/24/2003 | WO2003059952A1 Bispecific antibody dna constructs for intramuscular administration |
| 07/24/2003 | WO2003059951A2 Novel anti-igf-ir antibodies and uses thereof |
| 07/24/2003 | WO2003059950A1 Ifnar2 mutants, their production and use |
| 07/24/2003 | WO2003059942A2 Peptides and peptidomimetics having anti-proliferative activity and their use |
| 07/24/2003 | WO2003059939A1 Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds |
| 07/24/2003 | WO2003059927A1 Compositions and methods relating to endometrial specific genes and proteins |
| 07/24/2003 | WO2003059924A1 Novel binding epitopes for helicobacter pylori and use thereof |
| 07/24/2003 | WO2003059921A1 Mmp inhibitors |
| 07/24/2003 | WO2003059913A1 Roh-kinase inhibitors |
| 07/24/2003 | WO2003059907A1 Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof |
| 07/24/2003 | WO2003059899A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |
| 07/24/2003 | WO2003059898A2 Eponemycin and epoxomicin analogs and uses thereof |